Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bergstrand

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Pharmaceutical Research|February 4, 2017
In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial StatusBenjamin Guiastrennec, Erik Söderlind, Sara Richardson, et al.
The AAPS Journal|January 31, 2012
A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) modelEmilie Hénin, Martin Bergstrand, Joseph F Standing, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 14, 2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modelingAnna M Mc Laughlin, Peter A Milligan, Cassian Yee, et al.
The AAPS Journal|February 9, 2011
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects modelsMartin Bergstrand, Andrew C Hooker, Johan E Wallin, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 1, 2017
Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarction
Daniel Röshammar, Martin Bergstrand, Tomas Andersson, et al.
Pharmaceutical Research|September 28, 2011
A semi-mechanistic modeling strategy for characterization of regional absorption properties and prospective prediction of plasma concentrations following administration of new modified release formulationsMartin Bergstrand, Erik Söderlind, Ulf G Eriksson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in childrenMirjam N Trame, Martin Bergstrand, Mats O Karlsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2025
Exposure-Response Analysis for Time-to-Event Data in the Presence of Adaptive Dosing: Efficient Approaches and PitfallsAlexandra Lavalley-Morelle, Félicien Le Louedec, Richard Anziano, et al.
Pharmaceutical Research|September 28, 2011
A semi-mechanistic modeling strategy to link in vitro and in vivo drug release for modified release formulationsMartin Bergstrand, Erik Söderlind, Ulf G Eriksson, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 15, 2012
Serial correlation in optimal design for nonlinear mixed effects modelsJoakim Nyberg, Richard Höglund, Martin Bergstrand, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Pharmaceutical Research|February 4, 2017
In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial StatusBenjamin Guiastrennec, Erik Söderlind, Sara Richardson, et al.
The AAPS Journal|January 31, 2012
A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) modelEmilie Hénin, Martin Bergstrand, Joseph F Standing, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 14, 2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modelingAnna M Mc Laughlin, Peter A Milligan, Cassian Yee, et al.
The AAPS Journal|February 9, 2011
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects modelsMartin Bergstrand, Andrew C Hooker, Johan E Wallin, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 1, 2017
Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarction
Daniel Röshammar, Martin Bergstrand, Tomas Andersson, et al.
Pharmaceutical Research|September 28, 2011
A semi-mechanistic modeling strategy for characterization of regional absorption properties and prospective prediction of plasma concentrations following administration of new modified release formulationsMartin Bergstrand, Erik Söderlind, Ulf G Eriksson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in childrenMirjam N Trame, Martin Bergstrand, Mats O Karlsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2025
Exposure-Response Analysis for Time-to-Event Data in the Presence of Adaptive Dosing: Efficient Approaches and PitfallsAlexandra Lavalley-Morelle, Félicien Le Louedec, Richard Anziano, et al.
Pharmaceutical Research|September 28, 2011
A semi-mechanistic modeling strategy to link in vitro and in vivo drug release for modified release formulationsMartin Bergstrand, Erik Söderlind, Ulf G Eriksson, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 15, 2012
Serial correlation in optimal design for nonlinear mixed effects modelsJoakim Nyberg, Richard Höglund, Martin Bergstrand, et al.
Pageof 4